These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1627248)

  • 1. Does the HIV envelope induce a chronic graft-versus-host-like disease?
    Habeshaw J; Hounsell E; Dalgleish A
    Immunol Today; 1992 Jun; 13(6):207-10. PubMed ID: 1627248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human trials of AIDS vaccines: current status and future directions.
    Koff WC; Fauci AS
    AIDS; 1989; 3 Suppl 1():S125-9. PubMed ID: 2558684
    [No Abstract]   [Full Text] [Related]  

  • 3. Positive response. Encouraging results in the search for an AIDS vaccine.
    Beardsley T
    Sci Am; 1991 Aug; 265(2):26. PubMed ID: 1862329
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
    Dis Markers; 1991; 9(1):51. PubMed ID: 1742945
    [No Abstract]   [Full Text] [Related]  

  • 5. The envelope of HIV-1 as a key component to infectivity.
    Buchbinder A
    Prog AIDS Pathol; 1990; 2():1-11. PubMed ID: 2103853
    [No Abstract]   [Full Text] [Related]  

  • 6. Two additional AIDS vaccines approved for clinical trials.
    J Am Osteopath Assoc; 1991 May; 91(5):433. PubMed ID: 2061098
    [No Abstract]   [Full Text] [Related]  

  • 7. Epitope specificity of MHC restricted cytotoxic T lymphocytes induced by candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S73-5. PubMed ID: 7532425
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenicity of synthetic peptides corresponding to various epitopes of the human immunodeficiency virus envelope protein.
    Zaghouani H; Hall B; Shah H; Bona C
    Adv Exp Med Biol; 1991; 303():53-62. PubMed ID: 1725238
    [No Abstract]   [Full Text] [Related]  

  • 9. AIDS pathogenesis: HIV envelope and its interaction with cell proteins.
    Habeshaw JA; Dalgleish AG; Bountiff L; Newell AL; Wilks D; Walker LC; Manca F
    Immunol Today; 1990 Nov; 11(11):418-25. PubMed ID: 2078296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [AIDS--HIV envelope protein improves vaccination response].
    GURTLER L
    Fortschr Med; 1991 Dec; 109(35):10-1. PubMed ID: 1774002
    [No Abstract]   [Full Text] [Related]  

  • 11. Gp160 of commercial HIV western blots is not gp160env. Should criteria for seropositivity be revised?
    Fenouillet E; Blanes N; Gluckman JC
    AIDS; 1991 Jun; 5(6):770. PubMed ID: 1883550
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccination with gp160 in HIV.
    Seligman SJ
    N Engl J Med; 1992 Jan; 326(5):347; author reply 348. PubMed ID: 1558566
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenic and antigenic properties of an HIV-1 gp120-derived multiple chain peptide.
    Kelker HC; Schlesinger D; Valentine FT
    J Immunol; 1994 Apr; 152(8):4139-48. PubMed ID: 8144976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which gp160 vaccine?
    Moore J; Lewis GK; Robinson J
    Nature; 1993 Feb; 361(6412):503. PubMed ID: 7679205
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein.
    Martinon F; Gras-Masse H; Boutillon C; Chirat F; Deprez B; Guillet JG; Gomard E; Tartar A; Levy JP
    J Immunol; 1992 Nov; 149(10):3416-22. PubMed ID: 1385524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentially negative effects of AIDS vaccines based on recombinant viruses carrying HIV-1 derived envelope gene. A warning on AIDS vaccine development.
    Veljkovic V; Metlas R
    Vaccine; 1993; 11(3):291-2. PubMed ID: 8447156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
    Fenouillet E; Miquelis R; Drillien R
    Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [AIDS vaccine--its strategies and prospects].
    Kitamura T
    Nihon Rinsho; 1993 Sep; 51 Suppl():530-5. PubMed ID: 8271432
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic value of antibodies against HIV-1 proteins in seropositive drug addicts tested by the western blotting method].
    Swiderska H; Kalinowska B
    Przegl Epidemiol; 1992; 46(1-2):19-25. PubMed ID: 1475386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.